Amneal denied summary judgment against US states’ antitrust case over Phenytoin
By Clayton Vickers ( April 16, 2026, 20:21 GMT | Insight) -- Amneal Pharmaceuticals’ motion for judgment against claims it fixed prices has been denied, but the US states and territories suing the company must now focus on alleging Amneal carried out a conspiracy over the anti-seizure medication Phenytoin alone, and not that it participated in a larger conspiracy over some 80 generic drugs.Amneal Pharmaceuticals’ motion for judgment against claims it fixed prices has been denied, but the US states and territories suing the company must now focus on alleging Amneal carried out a conspiracy over the anti-seizure medication Phenytoin alone, and not that it participated in a larger conspiracy over some 80 generic drugs....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.